Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 07 Aug 2024

Effect of dexmedetomidine on ncRNA and mRNA profiles of cerebral ischemia-reperfusion injury in transient middle cerebral artery occlusion rats model

in Neuropharmacology

Zhen Zhen Zhang
Abdul Nasir
Dong Li
Suliman Khan
Qian Bai
Feng Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437445

1,505 views

Original Research

Published on 06 Aug 2024

Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis

in Neuropharmacology

Jing Peng
Linhui Liu
Qiaoling Li
Maochang Liu
Rong Zhou
Li Chen
Zhisheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407897

1,428 views

Original Research

Published on 06 Aug 2024

Data mining and safety analysis of dual orexin receptor antagonists (DORAs): a real-world pharmacovigilance study based on the FAERS database

in Neuropharmacology

Manxue Jiang
Hao Li
Lingti Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436405

2,345 views
1 citation

Original Research

Published on 06 Aug 2024

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model

in Neuropharmacology

Daniele Lana
Chiara Traini
Irene Bulli
Giorgia Sarti
Giada Magni
Selene Attorre
Maria Grazia Giovannini
Maria Giuliana Vannucchi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451114

2,535 views
5 citations

Original Research

Published on 06 Aug 2024

YAP activation in Müller cells protects against NMDA-induced retinal ganglion cell injury by regulating Bcl-xL expression

in Neuropharmacology

Toshihide Kashihara
Yui Morita
Misaki Hatta
Sae Inoue
Yume Suzuki
Akane Morita
Tsutomu Nakahara

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446521

1,539 views

Editorial

Published on 06 Aug 2024

Editorial: Advanced neural stem cell therapies for spinal cord injury

in Neuropharmacology

Venkatesh Katari
Santhosh Kumar Pasupuleti
Madhubanti Mullick
Vinod Kumar Reddy Lekkala
Dwaipayan Sen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469535

1,018 views
1 citation

Original Research

Published on 02 Aug 2024

Selective inhibitor of sodium-calcium exchanger, SEA0400, affects NMDA receptor currents and abolishes their calcium-dependent block by tricyclic antidepressants

in Neuropharmacology

Sergei I. Boikov
Tatiana V. Karelina
Dmitry A. Sibarov
Sergei M. Antonov

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432718

1,291 views
2 citations

Review

Published on 02 Aug 2024

Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases

in Neuropharmacology

Yuanshu Shi
Ping Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449101

4,511 views
6 citations

Systematic Review

Published on 02 Aug 2024

Natural herbal extract roles and mechanisms in treating cerebral ischemia: A systematic review

in Neuropharmacology

Jiashuo Yang
Bo Yu
Jian Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424146

1,537 views
1 citation

Clinical Trial

Published on 01 Aug 2024

Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial

in Neuropharmacology

Damiana Scuteri
Martina Pagliaro
Isabel Mantia
Marianna Contrada
Loris Pignolo
Paolo Tonin
Pierluigi Nicotera
Giacinto Bagetta
Maria Tiziana Corasaniti
the Pilot BRAINAID Trial investigators

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1417851

1,718 views
1 citation

Original Research

Published on 01 Aug 2024

Timed sulfonylurea modulation improves locomotor and sensory dysfunction following spinal cord injury

in Neuropharmacology

Guo-Ying Xu
Manjit Maskey
Zizhen Wu
Qing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440198

741 views

Editorial

Published on 31 Jul 2024

Editorial: Women in neuropharmacology 2023

in Neuropharmacology

Paola Sacchetti

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441780

694 views

Systematic Review

Published on 31 Jul 2024

The relation between Parkinson’s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis

in Neuropharmacology

Amal Mohammad Badawoud
Lashin Saad Ali
Mahmoud S. Abdallah
Ramy M. El Sabaa
Mostafa M. Bahaa
Thanaa A. Elmasry
Eman Wahsh
Mohamed Yasser
Nashwa Eltantawy
Mamdouh Eldesoqui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1434512

1,896 views
2 citations

Original Research

Published on 31 Jul 2024

Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases

in Neuropharmacology

Qiaofang Liang
Xiaolin Liao
Hongwen Wu
Yushen Huang
Taolin Liang
Hailong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431562

3,854 views
3 citations

Editorial

Published on 29 Jul 2024

Editorial: Identifying novel drug delivery systems and treatments for hearing loss and related ear disorders, volume II

in Neuropharmacology

Sho Kanzaki
Taro Yamaguchi
Myung-Whan Suh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464254

688 views

Original Research

Published on 29 Jul 2024

Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer’s disease

in Neuropharmacology

Zsolt Gáll
Bernadett Boros
Krisztina Kelemen
Melinda Urkon
István Zolcseak
Kincső Márton
Melinda Kolcsar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447757

2,569 views
1 citation

Navigation group

Articles

Effect of dexmedetomidine on ncRNA and mRNA profiles of cerebral ischemia-reperfusion injury in transient middle cerebral artery occlusion rats model

Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis

Data mining and safety analysis of dual orexin receptor antagonists (DORAs): a real-world pharmacovigilance study based on the FAERS database

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model

YAP activation in Müller cells protects against NMDA-induced retinal ganglion cell injury by regulating Bcl-xL expression

Editorial: Advanced neural stem cell therapies for spinal cord injury

Selective inhibitor of sodium-calcium exchanger, SEA0400, affects NMDA receptor currents and abolishes their calcium-dependent block by tricyclic antidepressants

Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases

Natural herbal extract roles and mechanisms in treating cerebral ischemia: A systematic review

Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial

Timed sulfonylurea modulation improves locomotor and sensory dysfunction following spinal cord injury

Editorial: Women in neuropharmacology 2023

The relation between Parkinson’s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis

Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases

Editorial: Identifying novel drug delivery systems and treatments for hearing loss and related ear disorders, volume II

Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer’s disease